Cyclerion Therapeutics, Inc. (CYCN) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 61 transactions totaling $33.2M, demonstrating a bullish sentiment with $32.8M in net insider flow. The most recent transaction on Jan 1, 2024 involved a transaction of 50,000 shares valued at $0.
No significant insider buying has been recorded for CYCN in the recent period.
No significant insider selling has been recorded for CYCN in the recent period.
Based on recent SEC filings, insider sentiment for CYCN is bullish with an Insider Alignment Score of 99/100 and a net flow of $32.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Cyclerion Therapeutics, Inc. (CYCN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading CYCN stock, having executed 61 transactions in the past 90 days. The most active insider is Terrance Mcguire (Executive), who has made 10 transactions totaling $10.3M.
Get notified when executives and directors at CYCN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2024 | Margaret Graul Regina | Executive | Award | 50,000 | $N/A | $0 | |
| Jan 1, 2024 | M. Hecht Peter | Executive | Award | 15,000 | $N/A | $0 | |
| Dec 1, 2023 | M. Hecht Peter | Executive | Award | 15,000 | $N/A | $0 | |
| Nov 30, 2023 | Hyman Steven | Executive | Award | 20,000 | $N/A | $0 | |
| Nov 30, 2023 | B. Desouza Errol | Executive | Award | 20,000 | $N/A | $0 | |
| Nov 30, 2023 | B. Desouza Errol | Executive | Award | 30,000 | $N/A | $0 | |
| Nov 30, 2023 | M. Hecht Peter | Executive | Award | 20,000 | $N/A | $0 | |
| Nov 30, 2023 | Mcguire Terrance | Executive | Award | 5,000 | $N/A | $0 | |
| Aug 9, 2023 | Mcguire Terrance | Executive | Sale | 8 | $3.40 | $27 | |
| May 19, 2023 | M. Hecht Peter | Executive | Award | 225,000 | $8.68 | $2.0M | Large |
| Jun 3, 2021 | Gerald Greenspan David | Executive | Purchase | 961,538 | $3.12 | $3.0M | Large |
| Jun 3, 2021 | M. Hecht Peter | Executive | Purchase | 823,170 | $3.28 | $2.7M | Large |
| Jun 3, 2021 | Mcguire Terrance | Executive | Purchase | 3,322 | $3.12 | $10.4K | |
| Jun 3, 2021 | Mcguire Terrance | Executive | Purchase | 92,831 | $3.12 | $289.6K | |
| May 6, 2021 | M. Hecht Peter | Executive | Purchase | 302,000 | $2.43 | $733.9K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $33.0M | 93.7% |
Award(A) | 36 | $2.0M | 5.5% |
Sale(S) | 9 | $240.0K | 0.7% |
Exercise(M) | 1 | $12.1K | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at Cyclerion Therapeutics, Inc. are accumulating shares at an accelerated pace. With 19 insiders making 61 transactions totaling $33.0M in purchases versus $240.0K in sales, the net buying activity of $32.8M signals strong executive confidence. Terrance Mcguire (Executive) leads the buying activity with $10.3M in transactions across all time.